Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share and Forecast 2031
Global Respiratory Syncytial Virus (RSV) Therapeutics Market is to reach USD 2.4 billion by 2027, and is projected to expand at a CAGR of 11.7% from 2023-2031.
